ProQomics
PrivateCompany Overview
ProQomics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. It was founded in 2024.
ProQomics is a biotechnology company that develops high-throughput proteoform quantitation platforms and analytical instruments to support drug discovery and biomarker research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProQomics Comparables
Compare ProQomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Post Translational Medicines | 76% |
For institutional investors. Book with your work email.
ProQomics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ProQomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProQomics's valuation, stock price, and market status.
Is ProQomics a public or private company?
ProQomics is a private company.
What is the current stock price of ProQomics?
ProQomics is a private company, so its shares have no public market price. Caplight tracks ProQomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProQomics worth (valuation)?
Valuation information for ProQomics is not publicly available.
Can I buy ProQomics stock?
ProQomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProQomics's last funding round?
Funding round information for ProQomics is not publicly available.
Who are the main investors in ProQomics?
Investor information for ProQomics is not publicly disclosed.
Will ProQomics IPO soon?
No public IPO plans have been announced for ProQomics.
How can I track ProQomics secondary market activity?
Caplight tracks bids, offers, and trades in ProQomics's shares on secondary markets.